Risk identification and management: MRI as a research tool in toxicology studies of new chemical entities.

Tengowski, Mark W; Kotyk, John J

Tengowski, Mark W; Kotyk, John J.

Affiliation

Tengowski MW; Pfizer Global Research and Development, Pfizer, Inc., 12800 Plymouth Road 16-1A/6, Ann Arbor, MI 48105, USA. mark.w.tengowski@pfizer.com

Prog Drug Res ; 62: 257-78, 2005.

Article in En | MEDLINE | ID: mdl-16329259

Subject(s)

Drug Evaluation, Preclinical; Magnetic Resonance Imaging; Toxicology; Animals; Brain/drug effects; Heart/drug effects; Humans; Kidney/drug effects; Liver/drug effects; Risk Assessment

Search on Google

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Toxicology / Magnetic Resonance Imaging / Drug Evaluation, Preclinical Type of study: Diagnostic_studies / Etiology_studies / Risk_factors_studies Limits: Animals / Humans Language: En Journal: Prog Drug Res Year: 2005 Type: Article Affiliation country: United States

Search on Google

XML

PubMed Links